| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crescent Biopharma, Inc. (CBIO) has 13 insiders with recent SEC Form 4 filings, including 8 buys and 3 sells. CBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.75M | $48.61M | - | |
| CEO | 323.5K | $5.72M | - | |
| COO | 153.7K | $2.72M | - | |
| Other | 70.0K | $1.24M | - | |
| Other | 54.2K | $958.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Rock Edwin45 | Chief Medical Officer | Buy | 200,000 | $1.55 | $309,000.00 | +200.0% | +122.4% | -18.2% | |
| Nov 11, 2022 | Semerjian Harout | Chief Executive Officer | Buy | 25,000 | $1.29 | $32,250.00 | New | +162.9% | -3.2% | |
| Nov 11, 2022 | Hahn Brian M.47 | SVP Finance, CFO | Buy | 20,000 | $1.06 | $21,200.00 | +54.3% | +162.9% | -3.2% | |
| Nov 11, 2022 | Magnani John L. | SVP Of Research, CSO | Buy | 45,045 | $1.17 | $52,702.65 | +14.0% | +162.9% | -3.2% | |
| Nov 11, 2022 | Girard Armand | SVP, Chief Business Officer | Buy | 6,500 | $1.05 | $6,825.00 | +28.7% | +162.9% | -3.2% | |
| Nov 11, 2022 | Pearson Timothy R | Director | Buy | 19,400 | $1.29 | $25,026.00 | +369.5% | +162.9% | -3.2% | |
| Mar 9, 2022 | Magnani John L. | SVP Of Research, CSO | Sell | 3,227 | $1.09 | $3,517.43 | -1.0% | -43.6% | +20.9% | |
| Mar 9, 2022 | Girard Armand | SVP, Chief Business Officer | Sell | 2,339 | $1.09 | $2,549.51 | -9.4% | -43.6% | +20.9% | |
| Mar 9, 2022 | Hahn Brian M.47 | SVP Finance, CFO | Sell | 2,917 | $1.09 | $3,179.53 | -7.3% | -43.6% | +20.9% | |
| Nov 16, 2021 | Andrews Patricia S | Director | Buy | 40,000 | $2.05 | $82,000.00 | +761.9% | -48.0% | -7.0% |